Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 03 2024
0mins
Source: Benzinga
Stock Performance Overview: Recursion Pharmaceuticals saw an 11.6% drop in shares following the announcement of Phase 2 data for a treatment, while Nikola's shares fell 10.4%. Conversely, Sify Technologies surged 103% after achieving NVIDIA certification, and several other companies experienced significant gains.
Market Losers: Windtree Therapeutics faced a 42.2% decline, with Dyne Therapeutics and Agape ATP also experiencing substantial drops of 31.7% and 31.3%, respectively, amidst various announcements regarding clinical trials and company transitions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
